Hostname: page-component-745bb68f8f-v2bm5 Total loading time: 0 Render date: 2025-01-22T11:37:33.873Z Has data issue: false hasContentIssue false
  • English
  • Français

Where are we Going with Drugs to Treat MS? Will Cost Continue to Increase?

Published online by Cambridge University Press:  02 December 2014

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 37 , Issue 3 , May 2010 , pp. 305 - 306
Copyright
Copyright © The Canadian Journal of Neurological 2010

References

1. Rotstein, DL, Mamdani, M, O’Connor, PW. Increasing use of disease modifying drugs for MS in Canada. Can J Neurol Sci. 2010; 37:383–8.Google Scholar
2. Tremlett, HL, Oger, J. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective. Mult Scler. 2008 Jan;14(1):94–105.Google Scholar
3. Cohen, JA, Barkhof, F, Comi, G, Hartung, HP, Khatri, BO, Montalban, X, et al. Oral fingolimod or intramuscular interferon for relapsing multiple Sclerosis. N Engl J Med. 2010;362(5):402–15.CrossRefGoogle ScholarPubMed
4. Giovannoni, G, Comi, G, Cook, S, Rammohan, K, Rieckmann, P, Sorensen, PS, et al. A placebo-controlled trial of Oral Cladribine for relapsing MS. N Engl J Med. 2010;362(5):416–26.Google Scholar
5. Government of Canada, Social Union, News release. A framework to improve the social union for Canadians an agreement between the Government of Canada and the Governments of the Provinces February 4, 1999 [cited 2010 Jan 23/] Available from: http://www.socialunion.gc.ca/news/024992.html Google Scholar
6. Thanassoulis, G, Karp, I, Humphries, K, Tu, JV, Eisenberg, MJ, Pilote, L. Impact of restrictive prescription plans on heart failure medication use. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):484–90.Google Scholar
7. Neutel, CI, Patten, SB. Sleep medication use in Canadian Seniors. Can J Pharmaco. 2009 Fall;16(3):e443–52.Google Scholar